Work

Randomized phase II study of preoperative chemoradiotherapy (CRT)+/- Panitumumab (P) followed by consolidation chemotherapy (C) in potentially operable locally advanced (stage IIIa, N2+) non-small cell lung cancer (LANSCLC): Nrg oncology/RTOG 0839.

Year: 2016

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2016.34.15_suppl.8510

Authors: Martin J. Edelman, Chen Hu, Quynh-Thu Le, Jessica Donington, Warren D. D'Souza, Adam Dicker, Billy W. Loo, Elizabeth Gore, Gregory M.M. Videtic, Nathaniel R. Evans, Joseph Leach, Maximilian Diehn, Steven J. Feigenberg, Yuhchyau Chen, Jeffrey D Bradley

Institutions: University of Maryland, Baltimore, NRG Oncology, Stanford Medicine, NYU Langone Health, University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Thomas Jefferson University, Sidney Kimmel Cancer Center, Stanford University, Medical College of Wisconsin, Cleveland Clinic, University of Rochester Medicine, Washington University in St. Louis

Language: English

Topic: Lung Cancer Diagnosis and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2891323219

Cites:

Cited by:

Related to: 10